Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shi-Yang-Xiao lotion is a **topically applied traditional Chinese medicine (TCM) formula** widely used for the treatment of **perianal eczema**. It is known for its potent **anti-inflammatory and antipruritic properties**, demonstrating **clinical efficacy in alleviating eczema-like skin lesions**. SYXL comprises multiple herbal compounds (UPLC-QTOF-MS/MS identified 93 compounds), but the precise full composition is not standardized in Western pharmacopeia. The **mechanism of action** centers on suppression of pro-inflammatory cytokines and inhibition of the **JAK2/STAT3 signaling pathway**, which translates to repair of the skin barrier, reduction of inflammation, and decrease in cytokines such as interleukin-1β, interleukin-6, and TNF-α.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Shi-Yang-Xiao lotion.